Sharechat Logo

FMA to pursue Strategic Finance directors over 'likely' Securities Act breaches

Thursday 7th February 2013

Text too small?

The Financial Markets Authority is preparing to file civil actions against the six directors of the failed finance company, Strategic Finance, saying it's concluded they are "likely to have breached the Securities Act".

The apparent breaches were in a prospectus, advertisement and investment statement issued between March and August 2008.

Strategic went into receivership in March 2010 owing approximately 11,000 investors $383 million, having been under moratorium arrangements since 2008.

The directors involved are Kerry Finnigan, Graham Edward Jackson, Marcel Aubrey Lindale, Timothy John Rich, Denis Grenville Thom and David John Wolfenden, the FMA said in a statement.

The directors are now to have an opportunity to respond to the FMA's proposed claim before civil proceedings are filed.

"FMA's role as a publicly-funded litigant, acting in the public interest, necessitates this announcement to keep the market and investors informed," said FMA Head of Enforcement, Belinda Moffat.

Strategic investors got a Christmas Eve distribution of 1.5 cents in the dollar, taking their return-to-date to 10 cents, and receiver John Fisk, from accounting firm PwC, estimates they will get between 12 percent and 20 percent of their original investment back.

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report